- Home
- Publications
- Publication Search
- Publication Details
Title
Asenapine: A Review in Schizophrenia
Authors
Keywords
Schizophrenia, Olanzapine, Last Observation Carry Forward, Asenapine, Lurasidone
Journal
CNS DRUGS
Volume 30, Issue 7, Pages 655-666
Publisher
Springer Nature
Online
2016-06-30
DOI
10.1007/s40263-016-0363-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Asenapine reduces anxiety-related behaviours in rat conditioned fear stress model
- (2016) Masayo Ohyama et al. ACTA NEUROPSYCHIATRICA
- Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study
- (2016) Toshihiko Kinoshita et al. PSYCHOPHARMACOLOGY
- Asenapine reduces anxiety-related behaviours in rat conditioned fear stress model
- (2016) Masayo Ohyama et al. ACTA NEUROPSYCHIATRICA
- Novel Atypical Antipsychotics: Metabolism and Therapeutic Drug Monitoring (TDM)
- (2015) Roberto Mandrioli et al. CURRENT DRUG METABOLISM
- The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
- (2015) Jennifer E. Thomas et al. Current Neuropharmacology
- Asenapine alters the activity of monoaminergic systems following its subacute and long-term administration: An in vivo electrophysiological characterization
- (2015) Chris A. Oosterhof et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation
- (2014) M. Pratts et al. ACTA PSYCHIATRICA SCANDINAVICA
- Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism
- (2014) Leslie Citrome Expert Opinion on Drug Metabolism & Toxicology
- Safety of antipsychotic drugs: focus on therapeutic and adverse effects
- (2014) Felix-Martin Werner et al. Expert Opinion On Drug Safety
- Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder
- (2014) David E. Kemp et al. JOURNAL OF CLINICAL PSYCHIATRY
- Early improvement as a predictor of treatment response and remission in patients with schizophrenia: A pooled, post-hoc analysis from the asenapine development program
- (2014) Stefan Leucht et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- Asenapine, Blonanserin, Iloperidone, Lurasidone, and Sertindole
- (2013) Sheng-Min Wang et al. CLINICAL NEUROPHARMACOLOGY
- A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach
- (2013) Leslie Citrome CNS DRUGS
- Management of schizophrenia: clinical experience with asenapine
- (2013) Leonardo Cortese et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: A pooled analysis
- (2013) Steven G. Potkin et al. SCHIZOPHRENIA RESEARCH
- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder
- (2012) Marc De Hert et al. CNS DRUGS
- Pharmacological and Clinical Profile of Recently Approved Second-Generation Antipsychotics
- (2012) Jeffrey Rado et al. DRUGS & AGING
- The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania
- (2012) Frank I Tarazi et al. Expert Opinion on Drug Discovery
- Meta-Analyses of the Efficacy of Asenapine for Acute Schizophrenia
- (2012) Armin Szegedi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow
- (2012) Olivia Frånberg et al. SYNAPSE
- Asenapine Pharmacokinetics in Hepatic and Renal Impairment
- (2011) Pierre Peeters et al. CLINICAL PHARMACOKINETICS
- Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis
- (2011) Steven L. Dubovsky et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Valproate Reduces the Glucuronidation of Asenapine Without Affecting Asenapine Plasma Concentrations
- (2011) Mireille G.F. Gerrits et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
- (2011) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
- (2011) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration
- (2011) John D. Elsworth et al. NEUROPHARMACOLOGY
- Comparison of QTc Data Analysis Methods Recommended by the ICH E14 Guidance and Exposure–Response Analysis: Case Study of a Thorough QT Study of Asenapine
- (2010) S Chapel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
- (2010) J. Schoemaker et al. PHARMACOPSYCHIATRY
- Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: Involvement of dopamine D1 receptors
- (2010) Kent Jardemark et al. SYNAPSE
- Modeling and Simulation of the Time Course of Asenapine Exposure Response and Dropout Patterns in Acute Schizophrenia
- (2009) LE Friberg et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic
- (2009) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Exposure-Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation
- (2009) Sunny Chapel et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Asenapine effects in animal models of psychosis and cognitive function
- (2009) Hugh M. Marston et al. PSYCHOPHARMACOLOGY
- Asenapine induces differential regional effects on serotonin receptor subtypes
- (2008) FI Tarazi et al. JOURNAL OF PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More